CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $70,000 | -93.2% | 58,000 | -89.9% | 0.00% | – |
| Q2 2022 | $1,033,000 | -44.9% | 573,476 | -38.2% | 0.00% | -100.0% |
| Q1 2022 | $1,876,000 | -18.7% | 928,242 | +9.0% | 0.00% | 0.0% |
| Q4 2021 | $2,308,000 | -30.6% | 851,622 | +14.1% | 0.00% | 0.0% |
| Q3 2021 | $3,328,000 | -18.4% | 746,069 | +6.1% | 0.00% | 0.0% |
| Q2 2021 | $4,079,000 | -12.5% | 703,245 | +5.9% | 0.00% | -50.0% |
| Q1 2021 | $4,664,000 | +69.3% | 664,334 | +15.8% | 0.00% | +100.0% |
| Q4 2020 | $2,755,000 | -17.7% | 573,799 | -0.1% | 0.00% | -50.0% |
| Q3 2020 | $3,348,000 | -10.6% | 574,186 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $3,745,000 | +44.0% | 554,752 | +35.7% | 0.00% | 0.0% |
| Q1 2020 | $2,600,000 | -21.2% | 408,755 | +29.1% | 0.00% | 0.0% |
| Q4 2019 | $3,300,000 | +170.3% | 316,534 | +2.0% | 0.00% | +100.0% |
| Q3 2019 | $1,221,000 | -72.8% | 310,451 | +3.0% | 0.00% | -66.7% |
| Q2 2019 | $4,483,000 | -38.0% | 301,445 | +3.5% | 0.00% | -40.0% |
| Q1 2019 | $7,229,000 | +45.0% | 291,228 | +4.9% | 0.01% | +25.0% |
| Q4 2018 | $4,986,000 | -39.3% | 277,596 | -0.7% | 0.00% | -20.0% |
| Q3 2018 | $8,213,000 | -31.8% | 279,628 | +5.5% | 0.01% | -44.4% |
| Q2 2018 | $12,047,000 | -0.7% | 264,926 | +15.3% | 0.01% | 0.0% |
| Q1 2018 | $12,130,000 | -19.3% | 229,734 | +4.0% | 0.01% | -25.0% |
| Q4 2017 | $15,023,000 | -13.1% | 220,924 | +5.3% | 0.01% | -20.0% |
| Q3 2017 | $17,296,000 | -2.6% | 209,894 | +10.7% | 0.02% | -11.8% |
| Q2 2017 | $17,755,000 | +59.7% | 189,627 | +8.6% | 0.02% | +54.5% |
| Q1 2017 | $11,121,000 | +73.8% | 174,666 | +21.3% | 0.01% | +57.1% |
| Q4 2016 | $6,399,000 | +30.8% | 144,043 | +6.1% | 0.01% | +16.7% |
| Q3 2016 | $4,894,000 | +238.9% | 135,736 | +29.0% | 0.01% | +200.0% |
| Q2 2016 | $1,444,000 | -26.1% | 105,186 | +3.4% | 0.00% | -33.3% |
| Q1 2016 | $1,954,000 | -43.0% | 101,742 | +3.8% | 0.00% | -40.0% |
| Q4 2015 | $3,430,000 | -60.8% | 97,997 | +2.9% | 0.01% | -61.5% |
| Q3 2015 | $8,755,000 | +18.5% | 95,200 | +13.2% | 0.01% | +30.0% |
| Q2 2015 | $7,391,000 | +22.4% | 84,094 | +3.4% | 0.01% | +25.0% |
| Q1 2015 | $6,037,000 | +39.6% | 81,317 | +5.3% | 0.01% | +33.3% |
| Q4 2014 | $4,324,000 | +28.2% | 77,212 | +3.9% | 0.01% | 0.0% |
| Q3 2014 | $3,373,000 | +17.8% | 74,348 | +7.6% | 0.01% | +20.0% |
| Q2 2014 | $2,863,000 | -30.2% | 69,115 | +16.8% | 0.01% | -28.6% |
| Q1 2014 | $4,099,000 | +19.1% | 59,161 | +3.6% | 0.01% | 0.0% |
| Q4 2013 | $3,443,000 | +26.3% | 57,124 | +30.0% | 0.01% | +16.7% |
| Q3 2013 | $2,727,000 | -1.6% | 43,943 | +10.5% | 0.01% | 0.0% |
| Q2 2013 | $2,770,000 | – | 39,771 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |